beyond pink team
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us
 If you are Breast Cancer Survivor and  you would like to contribute your story to our Newsletter, 
​please send us a message here.
DOWNLOAD Current NewsletteR

Categories

All
Advocacy
Bone Health
Breast Density
Breast Disease
Caregivers
COVID 19
COVID-19
Emotional Support
Environment
Exercise
Fatigue
Financial
Gender
Genetic Testing
Grief
High Risk
Hormone Replacement Therapy
Ignite
Implants
Intimacy After Cancer
LGBTQ
Lymphedema
Mammography
Meditation
Men
Mental Health
Metastasis
MRI
NBCC
Nutrition
Obesity
Pain
Pregnancy
Prevention
Radiation
Reconstruction
Reduce Risk
Rehabilitation
Screening
Sex
Side Effects
Support Groups
Surgery
Survivor
Survivorship
Treatment
Vaccine
Yoga
Young Women

Archives

January 2023
October 2022
July 2022
April 2022
January 2022
October 2021
July 2021
April 2021
January 2021
October 2020
July 2020
April 2020
January 2020
October 2019
July 2019
April 2019
January 2019
October 2018
July 2018
April 2018
January 2018
October 2017
July 2017
April 2017
January 2017
October 2016
July 2016
April 2016
January 2016
October 2015
July 2015
April 2015
January 2015
October 2014
July 2014
April 2014
January 2014
October 2013
July 2013
April 2013
January 2013
October 2012
July 2012
April 2012
January 2012
October 2011
July 2011
April 2011
January 2011
October 2010
July 2010
April 2010
January 2010
October 2009
July 2009
April 2009
January 2009
October 2008
July 2008
April 2008
January 2008
October 2007
July 2007
April 2007
January 2007
October 2006
July 2006
April 2006
January 2006
October 2005
July 2005
April 2005
January 2005
October 2004
July 2004
April 2004
January 2004

MRI: An Exciting New Imaging Tool in Breast Cancer Diagnosis and Treatment Planning

4/1/2005

0 Comments

 
by John Halloran, M.D.

Although MRI is not a new imaging tool, effective breast MRI for cancer detection has developed only over the last several years. For many years MRI has been used to evaluate breast implants for rupture and now is one of the most exciting and promising tools in the fight against breast cancer. There are two types of MRI scanners: “open MRI” and “high field MRI”. Open MR scanners have a more open design suited for patients who are claustrophobic. Another advantage of the “open MR” is that biopsies can be performed without having to remove the patient from the scanner. “High field” MR scanners have a short tunnel (called a gantry) and are similar in shape to a computed tomography (CT) scanner. MRI works by using a magnetic field.

Breast MRI examinations require the patient to have an intravenous (IV) catheter for administration of MRI contrast dye. Contrast is administered because it helps detect tumors. Many new, abnormal blood vessels form within tumors resulting in a much greater number of blood vessels in tumors than normal breast tissue. Consequently, more contrast dye localizes in the tumors than in the normal breast tissue making tumors appear “bright” and more easily identifiable on the MRI images. Some benign breast lesions may appear “bright” on MR images. Approximately one-third of lesions thought to be cancer on MR turn out to be benign lesions. Therefore, it is important to have the ability to perform MRI guided biopsies at the site performing breast MRI. This allows biopsy of tumors that may be evident only on MRI.

Advantages of MRI over mammography and CT include no radiation exposure and superior sensitivity in detection of subtle differences in the breast tissue. Disadvantages of MR include the cost and its limitation in distinguishing benign from malignant tumors.

Potential Uses of Breast MRI
  • Screening patients with breast implants and/or “dense” breasts
  • Breast cancer treatment planning: size and number of tumor(s)
  • Problem solver

“Dense” breast tissue may obscure breast cancer on mammography. Breast implants limit visibility of breast tissue on mammography. MRI does not have these limitations.

The sensitivity of mammography in the detection of cancer in “dense” breasts is reported between 45% to 60% compared to 81% to 95% for MRI. The most exciting capability of breast MRI may be its ability to assist in decisions regarding breast cancer treatment. Effective surgical planning and treatment of breast cancer depends on accurate assessment of the extent of the cancer, the size of the tumor, and the presence of other cancer sites.

MRI clearly is better than mammography in identifying additional sites of tumor. Breast cancer frequently is present at more than one site at the time of diagnosis. These other tumors may occur adjacent to the known tumor or even in the opposite breast. Identification of more than one tumor ​may change cancer therapy. The presence of more than one tumor may result in higher rates of cancer recurrence and may be a contraindication to breast conservation surgery. A University of Pennsylvania study showed more than one-third of patients with breast cancer had more extensive disease depicted on MR compared to mammography and treatment planning was altered in more than one-third of these patients (based on the MRI information).

​MRI effectively screens for cancer in the opposite breast. In an American College of Radiology Imaging Network study, 9% of patients diagnosed with breast cancer had a cancer in the opposite breast as well. MRI is very effective in determining the size of breast tumors. It has been used to follow the response of cancer to chemotherapy and in deciding between mastectomy and breast conservation surgery after completion of chemotherapy.

Breast MRI can be a problem solver. It is used to evaluate patients with inadequately visualized or indeterminate lesions on mammography and patients with atypical findings e.g., negative mammogram and enlarged axillary (arm pit) lymph nodes. A study by the University of Pennsylvania and Mayo Clinic showed MR clearly defined all breast lesions that were poorly demonstrated on mammography. In addition, MR successfully identified 86% of breast malignancies in patients with axillary lymph node metastases with an unknown site of breast cancer (by mammography and physical exam findings).

Breast MRI is an exciting advancement in breast cancer evaluation. Its diagnostic capabilities are invaluable and these capabilities will continue to grow with the constant advances in MRI technology.


​
Read Full Newsletter
0 Comments



Leave a Reply.

CONTACT US

Beyond Pink TEAM
c/o Jeanne Olson, Treasurer
1407 Asbury Lane
Waterloo, IA 50701
​beyondpinkteam@gmail.com
(319) 239-3706
©2020 Beyond Pink TEAM
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us